Anti-inflammatory Effects of the Fiber
Anti-inflammatory and Reactive Oxygen Species (ROS) Suppressive Effects of the Fiber Supplementation to a High Fat High Carbohydrate Meal and Fiber Supplementation Alone in Obese Patients With Type 2 Diabetes
1 other identifier
interventional
10
1 country
1
Brief Summary
This study will help elucidate the mechanism underlying the cardioprotective and anti-diabetes effect of dietary fiber by exploring a comprehensive set of inflammatory and oxidative stress markers, based on a contemporary understanding of this process. In addition, there have been very few studies that explored the immediate change in oxidative stress and incretin secretion after fiber intake. In this study, the investigators will be able assess the short term metabolic impact of dietary fiber at great details. The result will contribute to dietary recommendation or designing of fiber supplementation for prevention/treatment of diabetes, obesity and cardiovascular disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable type-2-diabetes
Started Jun 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 14, 2016
CompletedFirst Submitted
Initial submission to the registry
August 8, 2016
CompletedFirst Posted
Study publicly available on registry
August 16, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2018
CompletedResults Posted
Study results publicly available
October 17, 2024
CompletedOctober 17, 2024
October 1, 2024
1.6 years
August 8, 2016
December 30, 2023
October 16, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Peak Change in From Baseline in Reactive Oxygen Species (ROS) Generation
mononuclear cells will be isolated by Ficoll-Hypaque method and ROS will be measured by chemiluminescence as an index of NADPH oxidase activation. Measurment will take place at baseline before the meal intervention and hourly for 5 hrs after the meal. The percent change from baseline at peak effect will be calculated.
5hr
Secondary Outcomes (3)
Peak Change in From Baseline in Nuclear Factor-Kappa B (NFkB) Activation
5hr
Percent Change Toll Like Receptor-4 (TLR-4) Levels
5hr
Change in Plasma Lipopolysaccharides Level From Baseline.
5hr
Study Arms (2)
high fat high calorie meal (HFHC)
OTHERSubjects in this arm will receive high fat high calorie (HFHC) meal only
HFHC plus fiber
EXPERIMENTALSubjects in this arm will receive HFHC meal plus dietary fiber supplementation
Interventions
Fiber one supplement (32 grams of fiber) will be consumed with 910 Calorie HFHC meal
Eligibility Criteria
You may qualify if:
- Men and women 18 to 80 years of age
- Non-smoker (last cigarette at least one month ago)
- Type 2 diabetes for at least 1 year
- Body mass index \> 30 kg/m2
You may not qualify if:
- Participation in any other concurrent clinical trials
- Pregnancy or premenopausal women who are trying to be pregnant
- Patients who are incompetent to give consent
- Patients on non-steroidal anti-inflammatory drugs or steroids
- Concurrent disease that could disrupt intestinal epithelium and increase permeability to endotoxin, ie Celiac and Crohns disease.
- Hepatic disease (transaminase \> 3 times normal)
- Renal impairment (serum creatinine \> 1.5 mg/dl)
- History of drug or alcohol abuse
- Use of over the counter or prescribed probiotic supplements.
- Recent or current antibiotic use.
- Coronary artery disease (CAD): documented by history of myocardial infarction, angioplasty/stent placement, angina, exercise EKG positive for ischemia or angiographic evidence of CAD
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
ECMC Ambulatory Center, 3rd Floor
Buffalo, New York, 14215, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Paresh Dandona
- Organization
- State University of NY at Buffalo
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- SUNY Distinguished Professor
Study Record Dates
First Submitted
August 8, 2016
First Posted
August 16, 2016
Study Start
June 14, 2016
Primary Completion
January 1, 2018
Study Completion
July 1, 2018
Last Updated
October 17, 2024
Results First Posted
October 17, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share